Over the past few trading sessions AMEX:OCXhas had some bullish price action as earnings approach on 14the Aug. Technically the indicators have reversed in a bullish fashion and buy-side volume has increased consistently.
AVERAGE ANALYSTS PRICE TARGET $7.15
AVERAGE ANALYSTS RECOMMENDATION BUY
P/E RATIO
SHORT INTEREST
COMPANY PROFILE
OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.
AVERAGE ANALYSTS PRICE TARGET $7.15
AVERAGE ANALYSTS RECOMMENDATION BUY
P/E RATIO
SHORT INTEREST
COMPANY PROFILE
OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.